Marathon Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Marathon Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Sell	1,375 -1,275	-48%	-$219K	0.05%	154
2026 Q1	$447K	Hold	2,650	–	–	0.1%	112
2025 Q4	$447K	Sell	2,650 -165	-6%	-$26.8K	0.1%	114
2025 Q3	$406K	Sell	2,815 -500	-15%	-$68.3K	0.09%	109
2025 Q2	$419K	Sell	3,315 -300	-8%	-$36.8K	0.11%	107
2025 Q1	$462K	Hold	3,615	–	–	0.12%	98
2024 Q4	$478K	Hold	3,615	–	–	0.12%	96
2024 Q3	$526K	Hold	3,615	–	–	0.13%	92
2024 Q2	$496K	Hold	3,615	–	–	0.13%	92
2024 Q1	$496K	Hold	3,615	–	–	0.12%	94
2023 Q4	$491K	Hold	3,615	–	–	0.12%	97
2023 Q3	$442K	Sell	3,615 -200	-5%	-$25.4K	0.11%	96
2023 Q2	$484K	Sell	3,815 -100	-3%	-$13K	0.12%	96
2023 Q1	$506K	Sell	3,915 -200	-5%	-$26.2K	0.12%	98
2022 Q4	$540K	Buy	4,115 +100	+2%	+$12.9K	0.15%	89
2022 Q3	$470K	Buy	+4,015	New	+$499K	0.13%	98
2022 Q1	–	Sell	-3,715	Closed	-$567K	–	127
2021 Q4	$567K	Sell	3,715 -600	-14%	-$92.9K	0.13%	99
2021 Q3	$698K	Sell	4,315 -500	-10%	-$84.1K	0.16%	89
2021 Q2	$787K	Hold	4,815	–	–	0.18%	72
2021 Q1	$724K	Hold	4,815	–	–	0.19%	67
2020 Q4	$729K	Sell	4,815 -100	-2%	-$14.3K	0.21%	65
2020 Q3	$665K	Hold	4,915	–	–	0.24%	64
2020 Q2	$672K	Buy	+4,915	New	+$627K	0.26%	56

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Marathon Capital Management's IBB Position: Q2 2026 in Review

Marathon Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 48% in Q2 2026, selling an estimated $219K and leaving 1,375 shares worth $262K. The position accounts for 0.05% of the portfolio, ranked #154.

Marathon Capital Management first reported a position in IBB in Q2 2020 and has held it in 23 quarters since. The position peaked at $787K in Q2 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Marathon Capital Management held 1,375 shares of iShares Biotechnology ETF worth $262K as of Q2 2026.
Marathon Capital Management sold 1,275 iShares Biotechnology ETF shares in Q2 2026, an estimated $219K.
iShares Biotechnology ETF made up 0.05% of Marathon Capital Management's portfolio in Q2 2026, its #154 holding.
Marathon Capital Management first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 23 quarters since.
Marathon Capital Management's iShares Biotechnology ETF position peaked at $787K in Q2 2021.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Marathon Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.